ClinicalTrials.Veeva

Menu

Performance Assessment of a Modified Daily Disposable Contact Lens

Alcon logo

Alcon

Status

Completed

Conditions

Myopia
Refractive Errors
Hyperopia

Treatments

Device: Modified delefilcon A contact lenses
Device: Delefilcon A contact lenses

Study type

Interventional

Funder types

Industry

Identifiers

NCT03762668
CLP691-C002

Details and patient eligibility

About

The purpose of this study is to compare visual acuity between two daily disposable contact lenses.

Full description

The expected duration of subject participation in the study is approximately 2 weeks, with 3 scheduled visits.

Enrollment

62 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Able to understand and sign an approved Informed Consent form;
  • Current wearer of commercial DAILIES TOTAL1 Contact Lenses in both eyes;
  • Other protocol-specified inclusion criteria may apply.

Exclusion criteria

  • Any eye condition that contraindicates contact lens wear, as determined by the Investigator;
  • Any eye surgery that contraindicates contact lens wear, as determined by the Investigator;
  • Wears habitual contact lenses in an extended wear modality (routinely sleeping in lenses for at least 1 night per week)
  • Monocular (only one eye with functional vision);
  • Other protocol-specified exclusion criteria may apply.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

62 participants in 2 patient groups

MDACL, then DACL
Other group
Description:
Modified delefilcon A contact lenses (MDACL) worn first, followed by delefilcon A contact lenses (DACL), as randomized. Each product worn bilaterally (in both eyes) for approximately 1 week in a daily disposable modality.
Treatment:
Device: Delefilcon A contact lenses
Device: Modified delefilcon A contact lenses
DACL, then MDACL
Other group
Description:
DACL worn first, followed by MDACL, as randomized. Each product worn bilaterally for approximately 1 week in a daily disposable modality.
Treatment:
Device: Delefilcon A contact lenses
Device: Modified delefilcon A contact lenses

Trial documents
2

Trial contacts and locations

5

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems